# Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine

> **NCT02332954** · PHASE4 · COMPLETED · sponsor: **Lundbeck Canada Inc.** · enrollment: 226 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** vortioxetine

## Key facts

- **NCT ID:** NCT02332954
- **Lead sponsor:** Lundbeck Canada Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-07-06
- **Final completion:** 2017-07-06
- **Target enrollment:** 226 (ACTUAL)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02332954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02332954, "Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02332954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*